JP2001516721A - 免疫応答の調節 - Google Patents
免疫応答の調節Info
- Publication number
- JP2001516721A JP2001516721A JP2000511505A JP2000511505A JP2001516721A JP 2001516721 A JP2001516721 A JP 2001516721A JP 2000511505 A JP2000511505 A JP 2000511505A JP 2000511505 A JP2000511505 A JP 2000511505A JP 2001516721 A JP2001516721 A JP 2001516721A
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound
- animal
- alkyl
- immune response
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA97/8319 | 1997-09-16 | ||
ZA978319 | 1997-09-16 | ||
PCT/US1998/019126 WO1999013885A1 (fr) | 1997-09-16 | 1998-09-16 | Modulation de reactions immunitaires |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2001516721A true JP2001516721A (ja) | 2001-10-02 |
Family
ID=25586589
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000511505A Pending JP2001516721A (ja) | 1997-09-16 | 1998-09-16 | 免疫応答の調節 |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1019063A4 (fr) |
JP (1) | JP2001516721A (fr) |
CN (1) | CN1279612A (fr) |
AU (1) | AU737867B2 (fr) |
BR (1) | BR9812321A (fr) |
CA (1) | CA2304119A1 (fr) |
IL (1) | IL135091A0 (fr) |
NO (1) | NO20001341L (fr) |
NZ (1) | NZ503418A (fr) |
WO (1) | WO1999013885A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2324631A1 (fr) * | 2000-10-26 | 2002-04-26 | Virodene Pharmaceutical Holdings (Proprietary) Limited | Substance ou composition pour le traitement du cancer |
US20070212402A1 (en) * | 2003-12-05 | 2007-09-13 | Rooven Qainton V | Patch |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5814659A (en) * | 1996-04-23 | 1998-09-29 | Dtr Dermal Therapy (Barbados) Inc. | Topical analgesic composition |
-
1998
- 1998-09-16 JP JP2000511505A patent/JP2001516721A/ja active Pending
- 1998-09-16 AU AU93890/98A patent/AU737867B2/en not_active Ceased
- 1998-09-16 IL IL13509198A patent/IL135091A0/xx unknown
- 1998-09-16 EP EP98946998A patent/EP1019063A4/fr not_active Withdrawn
- 1998-09-16 CA CA002304119A patent/CA2304119A1/fr not_active Abandoned
- 1998-09-16 NZ NZ503418A patent/NZ503418A/xx not_active IP Right Cessation
- 1998-09-16 CN CN98810397A patent/CN1279612A/zh active Pending
- 1998-09-16 WO PCT/US1998/019126 patent/WO1999013885A1/fr not_active Application Discontinuation
- 1998-09-16 BR BR9812321-1A patent/BR9812321A/pt not_active IP Right Cessation
-
2000
- 2000-03-15 NO NO20001341A patent/NO20001341L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2304119A1 (fr) | 1999-03-25 |
AU737867B2 (en) | 2001-09-06 |
EP1019063A4 (fr) | 2003-09-03 |
CN1279612A (zh) | 2001-01-10 |
NZ503418A (en) | 2001-02-23 |
NO20001341L (no) | 2000-05-16 |
AU9389098A (en) | 1999-04-05 |
NO20001341D0 (no) | 2000-03-15 |
EP1019063A1 (fr) | 2000-07-19 |
BR9812321A (pt) | 2000-09-05 |
IL135091A0 (en) | 2001-05-20 |
WO1999013885A1 (fr) | 1999-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kaufman | Clinical cure of herpes simplex keratitis by 5-iodo-2'-deoxyuridine | |
KR102014883B1 (ko) | 근위축성 측삭 경화증 치료용 신규 조성물 | |
US20110020279A1 (en) | Rabies cure | |
JP2004518653A (ja) | 不安障害を治療する方法 | |
Wang et al. | Role of hypoxia‑inducible factor‑1α in autophagic cell death in microglial cells induced by hypoxia | |
Wu et al. | Recombinant osteopontin attenuates brain injury after intracerebral hemorrhage in mice | |
ES2948767T3 (es) | Moléculas orgánicas pequeñas para uso en el tratamiento de trastornos neuroinflamatorios | |
JPH11510143A (ja) | 注意不足/活動亢進障害の処置 | |
JP2001516721A (ja) | 免疫応答の調節 | |
US20040248984A1 (en) | Use of $g(b)-adrenoceptor agonists for the treatment of neurodegenerative diseases | |
WO2023019846A1 (fr) | Utilisation d'une neurotoxine cobra et sa préparation dans la préparation d'un médicament pour la prévention et le traitement de la maladie de parkinson | |
CN115120701A (zh) | 一种改善抑郁的组合物及其制备方法和应用 | |
CN105189449A (zh) | 非肽bdnf神经营养蛋白模拟物 | |
CN105311636B (zh) | 一种抗疱疹病毒软膏剂及其制备方法 | |
AU2022201835A1 (en) | Plant extracts enriched with ipolamiide derivatives as immunosuppressants for treating immunological disorders | |
Margolis et al. | Treatment of acute gouty arthritis with pituitary adrenocorticotropic hormone (ACTH) | |
ES2303441B1 (es) | Uso del acido valproico o de una sal farmaceuticamente aceptable del mismo para la prevencion y/o el tratamiento de la adenoleucodistrofia ligada a x. | |
Bodenham | Death after flumazenil. | |
JP7359377B2 (ja) | オキシトシン産生促進剤 | |
US3433875A (en) | The improvement of mental performance with potassium n-acetyl dl aminosuccinate | |
JPH08143465A (ja) | 難病のメガニズム及びその治療法 | |
WO2001049313A1 (fr) | Utilisation du facteur de croissance neuronale pour la production d'un medicament destine au traitement d'affections allergiques | |
KR102322102B1 (ko) | 염증성 질환의 예방, 개선 또는 치료용 조성물 | |
CN115300507B (zh) | I-brd9作为arih1激动剂的用途 | |
JP2017002043A (ja) | 神経損傷治療又は予防用医薬 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20050804 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20050804 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050909 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060421 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060421 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090427 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090727 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090803 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091027 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100201 |